<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Hypoplastic left heart syndrome: Anatomy, clinical features, and diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Hypoplastic left heart syndrome: Anatomy, clinical features, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Hypoplastic left heart syndrome: Anatomy, clinical features, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rahul H Rathod, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David R Fulton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 24, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H18895169"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Hypoplastic left heart syndrome (HLHS) is characterized by a diminutive left ventricle (LV) and small left-sided structures incapable of supporting the systemic circulation (<a class="graphic graphic_figure graphicRef82280" href="/z/d/graphic/82280.html" rel="external">figure 1</a>). If left untreated, HLHS is universally fatal. Surgical and medical interventions have improved outcomes, but mortality and morbidity remain high.</p><p>The anatomy, physiology, clinical features, and diagnosis of HLHS will be reviewed here. Management and outcome of HLHS and management of patients following the Fontan procedure are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/116293.html" rel="external">"Hypoplastic left heart syndrome: Management and outcome"</a> and  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation"</a>.)</p><p class="headingAnchor" id="H18895176"><span class="h1">PREVALENCE</span><span class="headingEndMark"> — </span>HLHS is the most common form of functional single-ventricle heart disease, with a birth prevalence of approximately two to three cases per 10,000 live births in the United States [<a href="#rid1">1-4</a>]. HLHS accounts for 2 to 3 percent of all congenital heart disease [<a href="#rid1">1,2</a>]. A male predominance (male to female ratio approximately 1.5:1) is observed in most population-based and clinical studies [<a href="#rid4">4,5</a>]. The reported overall incidence is likely underestimated because of the indeterminate rate of spontaneous abortions and elective termination of pregnancy of affected fetuses.</p><p>Despite its low incidence relative to other congenital cardiac disorders, HLHS, if left untreated, is responsible for 25 to 40 percent of all neonatal cardiac deaths.</p><p class="headingAnchor" id="H18895183"><span class="h1">ANATOMY</span><span class="headingEndMark"> — </span>HLHS is a spectrum of cardiac malformations with normally related great arteries characterized by underdevelopment of the left heart with significant hypoplasia of the left ventricle (LV) including atresia, stenosis or hypoplasia of the mitral and/or aortic valves, and hypoplasia of the ascending aorta and arch [<a href="#rid6">6</a>]. The anatomic variants of the disease are often distinguished by the status of the mitral and aortic valves (<a class="graphic graphic_figure graphicRef82280" href="/z/d/graphic/82280.html" rel="external">figure 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mitral atresia and aortic atresia (MA-AA) subtype</strong> – The MA-AA subtype is the most extreme form of HLHS. Both valves are atretic, and there is either an absent or a slit-like LV cavity and diminutive ascending aorta. With no possibility of LV output, this anatomic subtype is unequivocally identified as HLHS.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mitral stenosis and aortic atresia (MS-AA) subtype</strong> – In the MS-AA subtype, the ascending aorta is severely hypoplastic and systemic output is ductal-dependent. Depending on the degree of mitral stenosis, LV pressures may be subsystemic, systemic, or even suprastemic. The degree of ventricular hypertrophy is also variable, but there is usually severe LV systolic dysfunction.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mitral stenosis and aortic stenosis (MS-AS) subtype </strong>– At the mildest end of the spectrum is the "borderline left heart" (the MS-AS subtype), in which both valves are stenotic but not atretic. In some patients with MS-AS, the mitral and aortic valves are near-normal in size but a combination of LV diastolic and systolic dysfunction, or valvar stenosis, results in inadequate LV systemic output.</p><p></p><p>Neonates with HLHS physiology require a patent ductus arteriosus (PDA) to maintain adequate systemic circulation. Indeed, a ductal-dependent systemic circulation is a defining characteristic of the syndrome.</p><p class="headingAnchor" id="H635302"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The pathogenesis of HLHS is thought to be multifactorial, with alterations in blood flow and genetic factors contributing to the development. However, underlying causal mechanisms are poorly understood. Other possible contributing factors that have been suggested include intrauterine infarction, infection, and a selective left ventricular (LV) cardiomyopathy.</p><p class="headingAnchor" id="H370353043"><span class="h2">Altered blood flow</span><span class="headingEndMark"> — </span>One prevalent theory hypothesizes that "primary" anatomic defects of isolated left heart structures lead to altered blood flow through the left side of the heart, resulting in secondary malformations of the LV and outflow tract structures (sometimes called the "no flow, no grow" theory). The flow-based theory is supported by observational studies of human fetuses that reveal that aortic valve stenosis is an isolated early finding among fetuses who develop progressive prenatal hypoplasia of the left heart and neonatal HLHS [<a href="#rid7">7</a>]. In addition, animal studies have shown that obstructing flow results in severe structural heart defects [<a href="#rid8">8,9</a>].</p><p class="headingAnchor" id="H18895190"><span class="h2">Genetics</span><span class="headingEndMark"> — </span>There is growing evidence that genetic factors play a key role in the development of HLHS [<a href="#rid10">10</a>]. HLHS can occur in association with chromosomal aneuploidy and microdeletion syndromes, including Turner syndrome, Jacobsen syndrome, trisomy 13, trisomy 18, and DiGeorge syndrome [<a href="#rid11">11-13</a>]. However, these represent the minority of cases of HLHS and most affected neonates are nonsyndromic.</p><p>Single-gene mutations (eg, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F600584&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyrKnPRfO2suDlGsqsaho8UT&amp;TOPIC_ID=14370" target="_blank"><i>NKX2-5</i></a>) have also been implicated [<a href="#rid14">14</a>]. In one study, putative pathologic copy number variants were noted in 14 percent of patients with single-ventricle heart defects, compared with 4 percent of control subjects [<a href="#rid15">15</a>]. The genetic role in HLHS is also supported by the finding that the recurrence risk for HLHS in subsequent siblings is approximately 8 percent [<a href="#rid16">16</a>].</p><p>Genetic syndromes and genetic variants appear to be associated with greater risk of mortality and poor neurocognitive outcome in patients with HLHS [<a href="#rid15">15,17,18</a>]. (See  <a class="medical medical_review" href="/z/d/html/116293.html" rel="external">"Hypoplastic left heart syndrome: Management and outcome", section on 'Outcome'</a>.)</p><p class="headingAnchor" id="H635622"><span class="h1">PHYSIOLOGY</span><span class="headingEndMark"> — </span>With hypoplastic or atretic mitral and aortic valves, and a diminutive left ventricle (LV), the right ventricle (RV) must support both the pulmonary and systemic circulations. Survival is dependent on a patent ductus arteriosus (PDA) to ensure adequate systemic perfusion (from the RV to the aorta) and a nonrestrictive atrial septal defect (ASD) to ensure adequate mixing of oxygenated and deoxygenated blood. The relative distribution of RV output to the systemic and pulmonary circulations is dependent on the relative resistances of these parallel circuits.</p><p>At birth, there is typically a short "honeymoon" period when the ductus arteriosus is unrestrictive and pulmonary arteriolar resistance is relatively high. As a result, there is no restriction of adequately oxygenated systemic blood flow from the RV across the PDA and into the aorta. During this period, infants may be relatively asymptomatic. However, two normal physiologic post-delivery events, PDA closure and a reduction in pulmonary vascular resistance, lead to a decrease in systemic perfusion and an increase in pulmonary blood flow. If HLHS is not recognized and treated (eg, with prostaglandin E1 infusion) prior to the occurrence of these physiologic events, cardiogenic shock and respiratory failure will ensue. (See  <a class="medical medical_review" href="/z/d/html/4970.html" rel="external">"Physiologic transition from intrauterine to extrauterine life", section on 'Circulatory changes'</a>.)</p><p>In an estimated 10 percent of cases of HLHS, there is an inadequate or no defect in the atrial septum to allow egress of pulmonary venous return from the left atrium back to the RV [<a href="#rid19">19-21</a>]. A restrictive or intact atrial septum can result in increased pulmonary venous congestion and inadequate interatrial mixing of oxygenated and deoxygenated blood. Patients with this physiology present after delivery with severe cyanosis and acidosis and rapidly deteriorate with hemodynamic instability and shock. This occurs most commonly in patients with mitral atresia. Urgent intervention to create a larger atrial communication is required for survival [<a href="#rid21">21</a>]. In some patients with restrictive or intact atrial septum, the left atrium may be partially decompressed if there is a levoatrial cardinal vein, but this often does not preclude the need for eventual ASD enlargement. (See <a class="local">'Postnatal presentation'</a> below and  <a class="medical medical_review" href="/z/d/html/116293.html" rel="external">"Hypoplastic left heart syndrome: Management and outcome", section on 'Initial stabilization'</a>.)</p><p class="headingAnchor" id="H1942406903"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H1247847362"><span class="h2">Postnatal presentation</span><span class="headingEndMark"> — </span>In most cases, HLHS can be identified on prenatal ultrasonography and fetal echocardiography. (See <a class="local">'Prenatal diagnosis'</a> below and  <a class="medical medical_review" href="/z/d/html/6755.html" rel="external">"Congenital heart disease: Prenatal screening, diagnosis, and management"</a>.)</p><p>In neonates who present postnatally, the timing of presentation varies and is dependent on the size and presence of an atrial septal defect (ASD) and patency of the ductus arteriosus. (See <a class="local">'Physiology'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span>Infants who do <strong>not</strong> have a restrictive ASD (approximately 90 percent of infants with HLHS) typically have a "honeymoon" period immediately after birth because of adequate systemic perfusion through a patent ductus arteriosus (PDA) and initially relatively high pulmonary vascular resistance. In some cases, a dusky appearance due to cyanosis is noted in the newborn nursery, but other patients may appear normal and are occasionally discharged home [<a href="#rid22">22</a>]. As the PDA begins to close and pulmonary vascular resistance decreases, infants become symptomatic with a decrease in systemic perfusion manifested by diminished peripheral pulses and increasing pulmonary blood flow, which eventually leads to hypotension, acidosis, tachypnea, and respiratory distress. Symptoms can rapidly progress from cyanosis, increased respiratory distress, and poor feeding to heart failure and cardiogenic shock. (See <a class="local">'Physiology'</a> above and  <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">"Neonatal shock: Etiology, clinical manifestations, and evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infants with a restrictive or intact atrial septum present shortly after delivery with severe cyanosis and respiratory distress because of inadequate interatrial mixing of oxygenated and deoxygenated blood and increasing pulmonary venous congestion [<a href="#rid19">19-21</a>]. Without the urgent creation of an adequate interatrial communication, patients will develop cardiogenic shock and die.</p><p></p><p>If left untreated, 95 percent of neonates with HLHS die within the first few weeks of life [<a href="#rid23">23</a>].</p><p>Infants with HLHS are more likely to be born prematurely or at low birth weight than infants without HLHS [<a href="#rid24">24</a>]. Fetuses with HLHS have decreased growth velocity in late pregnancy compared with unaffected fetuses, resulting in small for gestational age presentation [<a href="#rid25">25</a>].</p><p class="headingAnchor" id="H2457131985"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>The following clinical features are typically found in the natural course of HLHS, although timing varies depending on the size of the ASD and patency of the ductus arteriosus:</p><p class="bulletIndent1"><span class="glyph">●</span>Cyanosis – Cyanosis is the most common feature of HLHS. The degree of cyanosis is determined by the relative states of pulmonary and systemic blood flow (ie, infants with very high pulmonary flow rates may have very mild degrees of cyanosis). Cyanosis does not resolve with supplemental oxygen.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tachypnea – Occasionally, if the ductus arteriosus remains patent and the pulmonary vascular resistance drops, tachypnea and respiratory distress can be part of the early presentation as pulmonary blood flow increases. Symptoms may also include retractions or gasping.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Heart sounds – Typically, <strong>no murmur</strong> is heard during cardiac auscultation. The second heart sound is single and loud, reflecting the absence of the aortic valve component and the associated pulmonary hypertension. In some infants, a pulmonary flow murmur may be present and the systolic murmur of tricuspid regurgitation may also be auscultated.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cool extremities – There may also be diminished peripheral pulses in infants with a low systemic output state.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hepatomegaly – Hepatomegaly may develop in patients with right ventricular (RV) dysfunction or tricuspid regurgitation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dysmorphic features – Patients should also be examined for dysmorphic features suggestive of an underlying syndrome. (See <a class="local">'Genetics'</a> above.)</p><p></p><p class="headingAnchor" id="H18895204"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Echocardiographic imaging, whether pre- or postnatal, is sufficient in most cases to make a diagnosis of HLHS. In both fetal and postnatal examinations, the anatomic features including a diminutive left ventricle (LV), abnormal mitral and aortic valves, and a hypoplastic ascending aorta are easily identified and confirm the diagnosis of HLHS.</p><p class="headingAnchor" id="H635588"><span class="h2">Prenatal diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of HLHS is made prenatally in approximately 50 to 75 percent of cases [<a href="#rid19">19,26,27</a>]. Prenatal diagnosis can be made on routine obstetrical ultrasound screening in the second trimester of pregnancy (typically between 18 and 24 weeks gestation), if the clinician recognizes the constellation of anatomic findings for HLHS (diminutive LV, abnormal mitral and aortic valves, and a hypoplastic ascending aorta). Some fetuses during this gestation timeframe may have a normal-sized LV without obvious flow disturbance across the mitral and aortic valves. Therefore, careful attention to other more subtle features can help identify those patients at risk for evolving HLHS. These may include [<a href="#rid7">7</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Left-to-right flow at the level of the atrial septum (normally, right-to-left in utero)</p><p class="bulletIndent1"><span class="glyph">●</span>Monophasic mitral valve inflow</p><p class="bulletIndent1"><span class="glyph">●</span>Retrograde flow in the transverse arch (due to the ascending aortic and coronary arterial flow being supplied via the ductus arteriosus)</p><p class="bulletIndent1"><span class="glyph">●</span>LV systolic dysfunction</p><p></p><p>Antenatal diagnosis can also be made with fetal echocardiography, which may be performed due to family history or other fetal anomalies [<a href="#rid26">26</a>]. (See  <a class="medical medical_review" href="/z/d/html/6755.html" rel="external">"Congenital heart disease: Prenatal screening, diagnosis, and management"</a>.)</p><p>Prenatal diagnosis allows time for parental education and counseling, for planning delivery at a tertiary care center with expertise in caring for neonates with HLHS [<a href="#rid28">28</a>], or for termination of pregnancy. Earlier screening (ie, during the first trimester) can identify some fetuses with HLHS and may also detect other noncardiac abnormalities [<a href="#rid29">29</a>]. In one report, first trimester screening was associated with a higher rate of pregnancy termination compared with second trimester screening [<a href="#rid29">29</a>].</p><p>Based on the available case series, there does not appear to be a difference in mortality between live-born infants diagnosed prenatally compared with postnatally diagnosed patients [<a href="#rid26">26,27,30</a>]. In a retrospective multicenter cohort of 591 infants with single-ventricle anatomy (HLHS in 66 percent), infants diagnosed prenatally were less likely to have acidosis, renal insufficiency, and shock at the time of stage I palliation compared with infants diagnosed postnatally. They also had shorter duration of mechanical ventilation postoperatively following stage I, but other postoperative outcomes, interstage course, and outcomes after stage II palliation (bidirectional Glenn) were similar between groups.</p><p class="headingAnchor" id="H635765"><span class="h2">Postnatal diagnosis</span></p><p class="headingAnchor" id="H578496317"><span class="h3">Echocardiography</span><span class="headingEndMark"> — </span>The characteristic echocardiographic findings of HLHS are a diminutive LV, abnormal mitral and aortic valves, and hypoplastic ascending aorta, which confirm the diagnosis (<a class="graphic graphic_movie graphicRef59781" href="/z/d/graphic/59781.html" rel="external">movie 1</a>). Segmental anatomy is normal, and the ventricular septum is intact. The mitral and/or aortic valves may be atretic or stenotic. The ascending aorta is often small and can be extremely diminutive in cases with aortic atresia. Ductal flow is typically bidirectional (right-to-left in systole). An atrial septal defect (ASD) is essential for survival, and flow is left to right.</p><p class="headingAnchor" id="H635787"><span class="h3">Other studies</span><span class="headingEndMark"> — </span>Although not diagnostic of HLHS, pulse oximetry, chest radiography, and electrocardiography (ECG) are often performed in the initial evaluation.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulse oximetry</strong> – Due to right-to-left flow across the patent ductus arteriosus (PDA) and mixing of oxygenated and deoxygenated blood, most neonates with HLHS will have an abnormal postductal saturation on pulse oximetry. For neonates not diagnosed prenatally, pulse oximetry screening may be more sensitive for detecting HLHS than physical examination alone [<a href="#rid31">31</a>]. (See  <a class="medical medical_review" href="/z/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ECG</strong> – Right-axis deviation and right ventricular (RV) hypertrophy are common ECG findings in patients with HLHS; however, these are nonspecific findings and are difficult to distinguish from the typical RV predominance seen in the ECG of normal neonates [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chest radiography</strong> – The chest radiographic findings vary and are nonspecific. In infants with increased pulmonary blood flow, typical findings include cardiomegaly and increased pulmonary vasculature. In infants with a restrictive or intact atrial septum, the chest radiography will reveal a "white out" appearance similar to that seen with obstructed total anomalous pulmonary venous connection.</p><p></p><p class="headingAnchor" id="H2036845168"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis for a newborn presenting with cyanosis, respiratory distress, and poor perfusion includes (see  <a class="medical medical_review" href="/z/d/html/14305.html" rel="external">"Approach to cyanosis in the newborn"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Other cyanotic congenital heart defects (<a class="graphic graphic_table graphicRef103087" href="/z/d/graphic/103087.html" rel="external">table 1</a>) (see  <a class="medical medical_review" href="/z/d/html/5774.html" rel="external">"Identifying newborns with critical congenital heart disease"</a> and  <a class="medical medical_review" href="/z/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Noncardiac causes of respiratory distress and cyanosis (eg, sepsis, pneumonia, persistent pulmonary hypertension of the newborn) (see  <a class="medical medical_review" href="/z/d/html/4964.html" rel="external">"Overview of neonatal respiratory distress and disorders of transition"</a> and  <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates"</a> and  <a class="medical medical_review" href="/z/d/html/5045.html" rel="external">"Persistent pulmonary hypertension of the newborn (PPHN): Clinical features and diagnosis"</a>)</p><p></p><p>Echocardiography distinguishes HLHS from these other conditions. (See <a class="local">'Echocardiography'</a> above.)</p><p class="headingAnchor" id="H1344200929"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/115414.html" rel="external">"Society guideline links: Congenital heart disease in infants and children"</a>.)</p><p class="headingAnchor" id="H70091851"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anatomy</strong> – Hypoplastic left heart syndrome (HLHS) is characterized by underdevelopment of the left-sided heart structures with significant hypoplasia of the left ventricle (LV), stenosis or atresia of the mitral and/or aortic valves, and hypoplasia of the ascending aorta and aortic arch (<a class="graphic graphic_figure graphicRef82280" href="/z/d/graphic/82280.html" rel="external">figure 1</a>). (See <a class="local">'Anatomy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence</strong> – The prevalence of HLHS is approximately 2 to 3 cases per 10,000 live births. Although HLHS accounts for only 2 to 3 percent of all congenital heart disease, it is a major congenital cardiac cause of neonatal mortality. (See <a class="local">'Prevalence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis and physiology</strong> – The causes of HLHS are unknown and are likely multifactorial. One proposed mechanism is that abnormal fetal development of left-sided heart structures (ie, the mitral and/or aortic valve) result in altered flow and consequent hypoplasia (sometimes called the "no flow, no grow" theory). Genetic factors also play a key role. The result of the anatomic defects in HLHS is that the right ventricle (RV) supports both the pulmonary and systemic circulation. Survival is dependent on a patent ductus arteriosus (PDA) for systemic perfusion and an unrestrictive atrial septal defect (ASD) for sufficient mixing of oxygenated and deoxygenated blood. (See <a class="local">'Prevalence'</a> above and <a class="local">'Pathogenesis'</a> above and <a class="local">'Physiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presentation</strong> – The timing and severity of presentation vary in neonates who are not diagnosed prenatally and are dependent on the presence and size of an ASD and patency of the ductus arteriosus. (See <a class="local">'Postnatal presentation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neonates who do <strong>not</strong> have a restrictive ASD appear to be asymptomatic during a "honeymoon" period after delivery and become symptomatic with PDA closure and as the pulmonary vascular resistance falls.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neonates with a restrictive or intact atrial septum are symptomatic at birth as there is inadequate interatrial mixing of oxygenated and deoxygenated blood and increasing pulmonary venous congestion due to limited egress of blood from the left atrium.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical findings</strong> – Physical findings that are commonly observed in the natural course of HLHS include cyanosis, respiratory distress, cool extremities, and decreased peripheral pulses. Typically, <strong>no murmur</strong> is heard during cardiac auscultation. (See <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of HLHS is made by echocardiography (<a class="graphic graphic_movie graphicRef59781" href="/z/d/graphic/59781.html" rel="external">movie 1</a>). Antenatal diagnosis is possible during a routine obstetrical ultrasound screening in the second trimester of pregnancy. (See <a class="local">'Diagnosis'</a> above and  <a class="medical medical_review" href="/z/d/html/6755.html" rel="external">"Congenital heart disease: Prenatal screening, diagnosis, and management"</a>.)</p><p></p><p class="headingAnchor" id="H1539475527"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Audrey Marshall, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Gordon BM, Rodriguez S, Lee M, Chang RK. Decreasing number of deaths of infants with hypoplastic left heart syndrome. J Pediatr 2008; 153:354.</a></li><li><a class="nounderline abstract_t">Reller MD, Strickland MJ, Riehle-Colarusso T, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008; 153:807.</a></li><li><a class="nounderline abstract_t">Fixler DE, Nembhard WN, Salemi JL, et al. Mortality in first 5 years in infants with functional single ventricle born in Texas, 1996 to 2003. Circulation 2010; 121:644.</a></li><li><a class="nounderline abstract_t">Karamlou T, Diggs BS, Ungerleider RM, Welke KF. Evolution of treatment options and outcomes for hypoplastic left heart syndrome over an 18-year period. J Thorac Cardiovasc Surg 2010; 139:119.</a></li><li><a class="nounderline abstract_t">Ohye RG, Sleeper LA, Mahony L, et al. Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 2010; 362:1980.</a></li><li><a class="nounderline abstract_t">Tchervenkov CI, Jacobs ML, Tahta SA. Congenital Heart Surgery Nomenclature and Database Project: hypoplastic left heart syndrome. Ann Thorac Surg 2000; 69:S170.</a></li><li><a class="nounderline abstract_t">Mäkikallio K, McElhinney DB, Levine JC, et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention. Circulation 2006; 113:1401.</a></li><li><a class="nounderline abstract_t">Reuter MS, Sokolowski DJ, Javier Diaz-Mejia J, et al. Decreased left heart flow in fetal lambs causes left heart hypoplasia and pro-fibrotic tissue remodeling. Commun Biol 2023; 6:770.</a></li><li><a class="nounderline abstract_t">Hove JR, Köster RW, Forouhar AS, et al. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 2003; 421:172.</a></li><li><a class="nounderline abstract_t">Benson DW, Martin LJ, Lo CW. Genetics of Hypoplastic Left Heart Syndrome. J Pediatr 2016; 173:25.</a></li><li><a class="nounderline abstract_t">Allan LD, Sharland GK, Milburn A, et al. Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. J Am Coll Cardiol 1994; 23:1452.</a></li><li><a class="nounderline abstract_t">Raymond FL, Simpson JM, Sharland GK, Ogilvie Mackie CM. Fetal echocardiography as a predictor of chromosomal abnormality. Lancet 1997; 350:930.</a></li><li><a class="nounderline abstract_t">Hinton RB, Martin LJ, Rame-Gowda S, et al. Hypoplastic left heart syndrome links to chromosomes 10q and 6q and is genetically related to bicuspid aortic valve. J Am Coll Cardiol 2009; 53:1065.</a></li><li><a class="nounderline abstract_t">McElhinney DB, Geiger E, Blinder J, et al. NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 2003; 42:1650.</a></li><li><a class="nounderline abstract_t">Carey AS, Liang L, Edwards J, et al. Effect of copy number variants on outcomes for infants with single ventricle heart defects. Circ Cardiovasc Genet 2013; 6:444.</a></li><li><a class="nounderline abstract_t">Hinton RB Jr, Martin LJ, Tabangin ME, et al. Hypoplastic left heart syndrome is heritable. J Am Coll Cardiol 2007; 50:1590.</a></li><li><a class="nounderline abstract_t">Newburger JW, Sleeper LA, Bellinger DC, et al. Early developmental outcome in children with hypoplastic left heart syndrome and related anomalies: the single ventricle reconstruction trial. Circulation 2012; 125:2081.</a></li><li><a class="nounderline abstract_t">Patel A, Hickey E, Mavroudis C, et al. Impact of noncardiac congenital and genetic abnormalities on outcomes in hypoplastic left heart syndrome. Ann Thorac Surg 2010; 89:1805.</a></li><li><a class="nounderline abstract_t">Stasik CN, Gelehrter S, Goldberg CS, et al. Current outcomes and risk factors for the Norwood procedure. J Thorac Cardiovasc Surg 2006; 131:412.</a></li><li><a class="nounderline abstract_t">Forbess JM, Cook N, Roth SJ, et al. Ten-year institutional experience with palliative surgery for hypoplastic left heart syndrome. Risk factors related to stage I mortality. Circulation 1995; 92:II262.</a></li><li><a class="nounderline abstract_t">Vlahos AP, Lock JE, McElhinney DB, van der Velde ME. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: outcome after neonatal transcatheter atrial septostomy. Circulation 2004; 109:2326.</a></li><li><a class="nounderline abstract_t">Abu-Harb M, Wyllie J, Hey E, et al. Presentation of obstructive left heart malformations in infancy. Arch Dis Child Fetal Neonatal Ed 1994; 71:F179.</a></li><li><a class="nounderline abstract_t">Hawkins JA, Doty DB. Aortic atresia: morphologic characteristics affecting survival and operative palliation. J Thorac Cardiovasc Surg 1984; 88:620.</a></li><li><a class="nounderline abstract_t">Hirsch JC, Copeland G, Donohue JE, et al. Population-based analysis of survival for hypoplastic left heart syndrome. J Pediatr 2011; 159:57.</a></li><li><a class="nounderline abstract_t">Cnota JF, Hangge PT, Wang Y, et al. Somatic growth trajectory in the fetus with hypoplastic left heart syndrome. Pediatr Res 2013; 74:284.</a></li><li><a class="nounderline abstract_t">Mahle WT, Clancy RR, McGaurn SP, et al. Impact of prenatal diagnosis on survival and early neurologic morbidity in neonates with the hypoplastic left heart syndrome. Pediatrics 2001; 107:1277.</a></li><li><a class="nounderline abstract_t">Brown DW, Cohen KE, O'Brien P, et al. Impact of prenatal diagnosis in survivors of initial palliation of single ventricle heart disease: analysis of the National Pediatric Cardiology Quality Improvement Collaborative database. Pediatr Cardiol 2015; 36:314.</a></li><li><a class="nounderline abstract_t">Morris SA, Ethen MK, Penny DJ, et al. Prenatal diagnosis, birth location, surgical center, and neonatal mortality in infants with hypoplastic left heart syndrome. Circulation 2014; 129:285.</a></li><li><a class="nounderline abstract_t">Jicinska H, Vlasin P, Jicinsky M, et al. Does First-Trimester Screening Modify the Natural History of Congenital Heart Disease? Analysis of Outcome of Regional Cardiac Screening at 2 Different Time Periods. Circulation 2017; 135:1045.</a></li><li><a class="nounderline abstract_t">Kipps AK, Feuille C, Azakie A, et al. Prenatal diagnosis of hypoplastic left heart syndrome in current era. Am J Cardiol 2011; 108:421.</a></li><li><a class="nounderline abstract_t">de-Wahl Granelli A, Wennergren M, Sandberg K, et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ 2009; 338:a3037.</a></li><li><a class="nounderline abstract_t">Monaco MA, Liberman L, Starc TJ, Silver ES. Defining the electrocardiogram in the neonate with hypoplastic left heart syndrome. Pediatr Cardiol 2015; 36:1014.</a></li></ol></div><div id="topicVersionRevision">Topic 14370 Version 49.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18534240" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Decreasing number of deaths of infants with hypoplastic left heart syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18657826" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20100974" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Mortality in first 5 years in infants with functional single ventricle born in Texas, 1996 to 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19909991" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Evolution of treatment options and outcomes for hypoplastic left heart syndrome over an 18-year period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20505177" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Comparison of shunt types in the Norwood procedure for single-ventricle lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10798427" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Congenital Heart Surgery Nomenclature and Database Project: hypoplastic left heart syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16534003" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37481629" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Decreased left heart flow in fetal lambs causes left heart hypoplasia and pro-fibrotic tissue remodeling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12520305" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26996724" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Genetics of Hypoplastic Left Heart Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8176106" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9314874" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Fetal echocardiography as a predictor of chromosomal abnormality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19298921" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Hypoplastic left heart syndrome links to chromosomes 10q and 6q and is genetically related to bicuspid aortic valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14607454" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : NKX2.5 mutations in patients with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24021551" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Effect of copy number variants on outcomes for infants with single ventricle heart defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17936159" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Hypoplastic left heart syndrome is heritable.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22456475" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Early developmental outcome in children with hypoplastic left heart syndrome and related anomalies: the single ventricle reconstruction trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20494032" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Impact of noncardiac congenital and genetic abnormalities on outcomes in hypoplastic left heart syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16434272" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Current outcomes and risk factors for the Norwood procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7586421" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Ten-year institutional experience with palliative surgery for hypoplastic left heart syndrome. Risk factors related to stage I mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15136496" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: outcome after neonatal transcatheter atrial septostomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7820713" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Presentation of obstructive left heart malformations in infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6207388" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Aortic atresia: morphologic characteristics affecting survival and operative palliation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21349542" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Population-based analysis of survival for hypoplastic left heart syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23770922" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Somatic growth trajectory in the fetus with hypoplastic left heart syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11389243" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Impact of prenatal diagnosis on survival and early neurologic morbidity in neonates with the hypoplastic left heart syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25135602" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Impact of prenatal diagnosis in survivors of initial palliation of single ventricle heart disease: analysis of the National Pediatric Cardiology Quality Improvement Collaborative database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24135071" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Prenatal diagnosis, birth location, surgical center, and neonatal mortality in infants with hypoplastic left heart syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28143885" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Does First-Trimester Screening Modify the Natural History of Congenital Heart Disease? Analysis of Outcome of Regional Cardiac Screening at 2 Different Time Periods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21624547" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Prenatal diagnosis of hypoplastic left heart syndrome in current era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19131383" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25605039" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Defining the electrocardiogram in the neonate with hypoplastic left heart syndrome.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
